Myomancy ADHD, Dyslexia and Autism

Vyvanse

April 2008

New Shire Holding Company Proposal - Earthtimes

Zacks Bull and Bear of the Day - Ad-Hoc-News (Pressemitteilung)

Shire climbs on talk of Pfizer bid interest - International Herald Tribune

Options Update: Shire Pharmaceuticals (SHPGY) & Amazon.com (AMZN) - The Options Insider

Zacks Bull and Bear of the Day Highlights: Research in Motion … - Centre Daily Times

Movers Roundup: Auxilium, China Unicom - CNNMoney.com

Movers Roundup: Auxilium, China Unicom - Houston Chronicle

Heavyweights Fall Hard - Medical Marketing and Media

March 2008

Shire and TAP to co-promote ulcerative colitis drug Lialda - Pharma Times (subscription)

Jefferies Expects Continued Shire Growth - Houston Chronicle

Shire Reports Increase In FY07 Profit, Revenue - Update - RTT News

Shire plc: IFRS Results for the Year Ending December 31, 2007 - MSN Money

ROUNDUP Shire delivers sales growth at the top end of consensus - Forbes

Shire soars on talk of Pfizer interest - Healthcare Digital

Shire climbs on talk that Pfizer is eager - Times Online

Shire shares soar on Pfizer bid rumours - Telegraph.co.uk

Shire up on Pfizer bid talk - Times Online

Is Pfizer Casting Attention on Shire? - Wall Street Journal

Five more drugs going to $22 under Tricare - ArmyTimes.com

BROKERWATCH Shire up to 'market perform' vs 'underperform' by … - Trading Markets (press release)

February 2008

AMRI stuck with stagnant sales - OutSourcing-Pharma.com

ROUNDUP Shire delivers sales growth at the top end of consensus - CNNMoney.com

Shire up on faint £14 a share rumour - Guardian Unlimited

Shire FY sales up 36 pct, net loss 1.45 bln usd vs 278 mln profit … - Forbes

Shire 2007 earnings top forecast, upbeat on Vyvanse - Therapeutics Daily (subscription) (press release)

UPDATE 1-Shire 2007 earnings top forecast, upbeat on Vyvanse - Reuters

Shire plc: Excellent Performance Across All Areas of the Business … - PR Newswire (press release)

Shire FY sales up 36 pct, net loss 1.45 bln usd vs 278 mln profit … - Interactive Investor

Shire "outperform," target price reduced - newratings.com

Thursday preview: Shire, BAE, Reed Elsevier - ShareCast

Premarket Roundup: Best Buy, Shire - Houston Chronicle

Shire: Excellent Performance Across All Areas of the Business and … - PharmaLive.com (press release)

Shire (SHPGY) NewsBite - Shire Profit Surges on Higher Vyvanse Sales - Market Intelligence Center

Shire Profit Triples on Sales of Vyvanse ADHD Drug (Update3) - Bloomberg

London shares outlook - up, after Wall Street rally; Centrica, BAE … - CNNMoney.com

Shire sales trump forecasts - ShareCast

Shire shares up after net income jumps - Philadelphia Inquirer

Shire plc: Excellent Performance Across All Areas of the Business … - Biloxi Sun Herald

STOCKWATCH Shire gains as FY numbers, Vyvanse sales beat estimates … - Trading Markets (press release)

Ahead of the Bell: Shire shares rise - MSN Money

Albany Molecular Research, Inc. Q4 2007 Earnings Call Transcript - Seeking Alpha

UK Stocks Gain, Led by Compass, BG; Biffa Surges on Takeover - Bloomberg

Out of the Gate: Shire Stock Falls - Houston Chronicle

London shares open up after recent falls, NY gain; Compass up on … - Hemscott

BG Group, BT, Compass, Rank, Shire: UK, Irish Stock Preview - Bloomberg

Broker tips: Provident Financial, Shire, Arriva, Go Ahead - ShareCast

Barclays and RBS warnings add to banking woes - Telegraph.co.uk

ADRs in Focus: Shire Falls on Downgrade - Conde Nast Portfolio

Experian calms investors's nerves - Guardian Unlimited

ADRs in Focus: Shire Rebounds - Forbes